S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
S&P 500   3,108.46 (-0.38%)
DOW   27,821.09 (-0.40%)
QQQ   202.15 (-0.45%)
AAPL   263.19 (-1.16%)
FB   197.51 (-0.91%)
MSFT   149.62 (-0.51%)
GOOGL   1,301.86 (-0.82%)
AMZN   1,745.53 (-0.41%)
CGC   17.64 (+15.14%)
NVDA   211.18 (+1.53%)
MU   45.57 (-2.17%)
BABA   182.35 (-1.57%)
GE   11.39 (-0.96%)
TSLA   352.22 (-2.03%)
T   37.18 (-2.16%)
AMD   40.98 (-0.75%)
ACB   2.64 (+12.82%)
F   8.73 (-1.91%)
PRI   131.52 (-0.09%)
NFLX   305.16 (+0.85%)
BAC   32.69 (-0.76%)
GILD   64.88 (-0.18%)
DIS   146.93 (-0.98%)
Log in

SAGE Therapeutics SEC Filings & 10K Form (NASDAQ:SAGE)

$151.52
+3.56 (+2.41 %)
(As of 11/20/2019 04:00 PM ET)
Add
Compare
Today's Range
$147.45
Now: $151.52▼
$152.80
50-Day Range
$135.13
MA: $142.04▼
$148.54
52-Week Range
$79.88
Now: $151.52▼
$193.56
Volume576,300 shs
Average Volume468,640 shs
Market Capitalization$7.85 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.49

SEC Filings

SAGE Therapeutics (NASDAQ:SAGE) SEC Filings

DateFilerForm TypeView
11/12/2019
6:16 AM		SAGE Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
5:44 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
4:00 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:33 PM		Kanes Stephen (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:04 PM		FRATES JAMES M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
6:16 AM		SAGE Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:04 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
7:00 PM		Cloonan Michael (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
7:00 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
7:00 PM		Robichaud Albert (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
6:59 PM		Kanes Stephen (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
6:59 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
6:58 PM		Cook Anne Marie (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
5:02 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
6:18 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:02 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:01 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:18 PM		Kanes Stephen (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:18 PM		Robichaud Albert (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:17 PM		Cook Anne Marie (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:16 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:16 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
8:03 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
3:36 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
3:02 PM		PAUL STEVEN M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		Nayak Asha (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		Golumbeski George (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		Germano Geno J (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		FRATES JAMES M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		COLA MICHAEL F (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		Barrett Elizabeth (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:02 PM		SAGE Therapeutics (Issuer)
STARR KEVIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:01 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
5:24 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
3:00 PM		Cloonan Michael (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:31 PM		Cook Anne Marie (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
5:21 PM		FRATES JAMES M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:25 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
6:16 AM		SAGE Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:04 PM		SAGE Therapeutics (Filer)
Form DEFA14A
04/25/2019
3:01 PM		SAGE Therapeutics (Filer)
Form DEF 14A
03/22/2019
3:22 PM		PAUL STEVEN M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
7:47 PM		PAUL STEVEN M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
8:08 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
4:03 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
4:48 PM		PAUL STEVEN M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:05 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
7:08 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
7:04 AM		SAGE Therapeutics (Filer)
Form 424B5
02/25/2019
3:07 PM		SAGE Therapeutics (Filer)
Form 424B5
02/20/2019
6:55 AM		PAUL STEVEN M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:50 AM		SAGE Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/19/2019
6:33 AM		SAGE Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2019
6:07 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
3:31 PM		Cook Anne Marie (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
3:31 PM		Cloonan Michael (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
3:30 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
7:30 PM		PAUL STEVEN M (Reporting)
SAGE Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2019
6:56 PM		Robichaud Albert (Reporting)
SAGE Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2019
4:45 PM		SAGE Therapeutics (Issuer)
STARR KEVIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:50 PM		PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
SAGE Therapeutics (Subject)
Form SC 13G/A
02/13/2019
8:32 AM		SAGE Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
4:08 PM		Kanes Stephen (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
4:28 PM		BlackRock Inc. (Filed by)
SAGE Therapeutics (Subject)
Form SC 13G/A
01/24/2019
4:44 PM		FRATES JAMES M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
4:29 PM		Barrett Elizabeth (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
4:29 PM		Golumbeski George (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
4:28 PM		Barrett Elizabeth (Reporting)
SAGE Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2019
4:24 PM		Golumbeski George (Reporting)
SAGE Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2019
4:03 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
4:16 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:30 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2018
3:33 PM		SAGE Therapeutics (Filer)
Form S-3ASR
12/11/2018
4:25 PM		JONAS JEFFREY M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
4:25 PM		Kanes Stephen (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
4:25 PM		Cook Anne Marie (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
4:25 PM		Robichaud Albert (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
4:25 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
11:13 AM		SAGE Therapeutics (Filer)
Form CT ORDER
11/20/2018
3:06 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:18 PM		SAGE Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/06/2018
6:55 AM		SAGE Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
5:46 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
4:26 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2018
4:20 PM		FRATES JAMES M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
6:32 AM		SAGE Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
6:30 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
6:30 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
6:30 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2018
3:30 PM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2018
6:30 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
3:51 PM		FRATES JAMES M (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
6:17 AM		SAGE Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2018
5:35 AM		SAGE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2018
4:44 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2018
3:35 PM		SAGE Therapeutics (Issuer)
STARR KEVIN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:14 PM		Cloonan Michael (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:14 PM		IGUCHI KIMI (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:14 PM		Cook Anne Marie (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:13 PM		Robichaud Albert (Reporting)
SAGE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: What strategies should day traders use to execute a trade?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel